Journal
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
Volume 40, Issue 7, Pages 3129-3131Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/07391102.2020.1845801
Keywords
Camelid; heavy-chain antibody; SARS-CoV-2; therapeutic; diagnostic
Categories
Ask authors/readers for more resources
COVID-19 is a highly contagious disease caused by SARS-CoV-2, with rapid global spread and high fatality rates. Currently, there are no available vaccines or specific therapies. This paper highlights the potential utility of nanobodies for therapeutic and diagnostic interventions.
Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by severe acute respiratory coronavirus 2 (SARS-CoV-2). This virus is capable of human-to-human transmission, and is spreading rapidly round the globe, with markedly high fatality rates. Unfortunately, there are neither vaccines nor specific therapies available to combat it, and the developments of such approaches depend on pursuing multiple avenues in biomedical science. Accordingly, in this paper we highlight one such avenue-nanobodies-for potential utility in therapeutic and diagnostic interventions to combat COVID-19. Communicated by Ramaswamy H. Sarma
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available